Neos Therapeutics, Inc. 4
4 · Neos Therapeutics, Inc. · Filed May 2, 2017
Insider Transaction Report
Form 4
Martens Juergen
Chief Tech/Operations Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-05-01+45,000→ 45,000 totalExercise: $7.00Exp: 2027-05-01→ Common Stock (45,000 underlying) - Award
Common Stock
2017-05-01+15,000→ 25,000 total
Footnotes (2)
- [F1]Represents shares of common stock underlying restricted stock unit grants awarded to the Reporting Person. The restricted stock units will vest in four equal, annual installments beginning on May 1, 2018.
- [F2]This stock option will vest in four equal, annual installments beginning on May 1, 2018.